High-Sensitive C-Reactive Protein Predicts Recurrent Stroke and Poor Functional Outcome: Subanalysis of the Clopidogrel in High-Risk Patients With Acute Nondisabling Cerebrovascular Events Trial [Clinical Sciences]
Conclusions—
High hsCRP levels predict recurrent stroke and poor functional outcome in acute patients with minor stroke or transient ischemic attack.
Clinical Trial Registration—
URL: http://www.clinicaltrials.gov. Unique identifier: NCT00979589.
Source: Stroke - Category: Neurology Authors: Li, J., Zhao, X., Meng, X., Lin, J., Liu, L., Wang, C., Wang, A., Wang, Y., Wang, Y., on behalf of the CHANCE Investigators Tags: Biomarkers, Inflammation, Ischemic Stroke, Transient Ischemic Attack (TIA) Clinical Sciences Source Type: research
More News: Clinical Trials | Clopidogrel | Ischemic Stroke | Men | Neurology | Plavix | Stroke | Study